Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE124333 | GEO | 2019/05/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [ChIP-seq]

Project description:ChIP-seq for H3K27Ac mark in MDSCs isloated from MDA-MB-231.X1.1 xenograft

2019-05-31 | GSE124331 | GEO

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [RNA-seq]

Project description:CBP bromodomain inhibitor effects on mouse MDSCs sorted out of MDA-MB-231.X1.1 xenograft

2019-05-31 | GSE124322 | GEO

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain

Project description:Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain

| PRJNA511660 | ENA

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [RNA-seq]

Project description:Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [RNA-seq]

| PRJNA511659 | ENA

Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [ChIP-seq]

Project description:Epigenetic regulation of tumor-associated myeloid cell activity by CBP/EP300 bromodomain [ChIP-seq]

| PRJNA511664 | ENA

Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.

Project description:Covalent modification of histones is a fundamental mechanism of regulated gene expression in eukaryotes, and interpretation of histone modifications is an essential feature of epigenetic control. Bromodomains are specialized binding modules that interact with acetylated histones, linking chromatin recognition to gene transcription. Because of their ability to function in a domain-specific fashion, selective disruption of bromodomain:acetylated histone interactions with chemical probes serves as a powerful means for understanding biological processes regulated by these chromatin adaptors. Here we describe the discovery and characterization of potent and selective small molecule inhibitors for the bromodomains of CREBBP/EP300 that engage their target in cellular assays. We use these tools to demonstrate a critical role for CREBBP/EP300 bromodomains in regulatory T cell biology. Because regulatory T cell recruitment to tumors is a major mechanism of immune evasion by cancer cells, our data highlight the importance of CREBBP/EP300 bromodomain inhibition as a novel, small molecule-based approach for cancer immunotherapy.

| S-EPMC4933219 | biostudies-literature

Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.

Project description:Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting the bromodomains of coactivators CREB (cyclic-AMP response element binding protein) binding protein (CBP) and E1A binding protein of 300 kDa (EP300) as potent enhancers of reprogramming. These inhibitors accelerate reprogramming, are critical during its early stages and, when combined with DOT1L inhibition, enable efficient derivation of human induced pluripotent stem cells (iPSCs) with OCT4 and SOX2. In contrast, catalytic inhibition of CBP/EP300 prevents iPSC formation, suggesting distinct functions for different coactivator domains in reprogramming. CBP/EP300 bromodomain inhibition decreases somatic-specific gene expression, histone H3 lysine 27 acetylation (H3K27Ac) and chromatin accessibility at target promoters and enhancers. The master mesenchymal transcription factor PRRX1 is one such functionally important target of CBP/EP300 bromodomain inhibition. Collectively, these results show that CBP/EP300 bromodomains sustain cell-type-specific gene expression and maintain cell identity.

| S-EPMC6504645 | biostudies-literature

Activity of EP300/CBP bromodomain inhibitor CCS1477 across diverse hematologic malignancies

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-11-28 | GSE207357 | GEO

Regulatory T cell modulation by CBP/EP300 bromodomain inhibition

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-04-08 | GSE70709 | GEO

Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-02-14 | GSE118220 | GEO